ABCT 2023 Cohort Information Session
Join us at this information session to learn first hand about the ABCT 2023 programs. Ask your questions in a virtual format. Hear about the...
Join us at this information session to learn first hand about the ABCT 2023 programs. Ask your questions in a virtual format. Hear about the...
Join us at this information session to learn first hand about the ABCT 2023 programs. Ask your questions in a virtual format. Hear about the...
Join this application review session to strengthen your program application ahead of the upcoming deadlines; hear from our team, as well as program alum, to...
The recent Supreme Court decision in Dobbs v. Jackson Women's Health Organization is creating compliance and coverage issues for employers and group health plans. Please join Aon...
Welcome to our 20th Annual Health Care & Life Sciences Awards! This regional event attracts over 200 health care practitioners, bioscience executives, researchers, purchasing managers, marketing...
Join us at this information session to learn first hand about the ABCT 2023 programs. Ask your questions in a virtual format. Hear about the...
The Red Zone is a state of being where heightened stress tips a person out of alignment. For most of us, stress used to gradually...
Join MassBioEdge Partner Veolia for training on hazardous waste and emergency response during their First Responder Operations Level - HAZWOPER Refresher Course. Veolia's First Responder Operations Level...
Join this application review session to strengthen your program application ahead of the upcoming deadlines; hear from our team, as well as program alum, to...
Humanized immune system (HIS) mice are critical to preclinical investigations of infectious diseases, like HIV, prior to clinical studies. Furthermore, these models can be used...
It’s been one year since the passage of the IRA. The Centers for Medicare & Medicaid Services has moved forward implementing the law’s various provisions, including the new Medicare negotiation program and the redesign of the Medicare Part D benefit. Learn the latest developments from our panel of experts, including how the IRA is impacting biopharmaceutical companies today. Panelists will delve into other important issues beyond the IRA, including new developments in Medicaid, 340B, and the emergence of Prescription Drug Affordability Boards in a number of states.
Moderator:
John Murphy, Chief Policy Officer, BIO
Speakers:
Crystal Kuntz, SVP, Health Policy & Reimbursement, BIO
Erin Hertzog, Partner, Foley Hoag LLP
Jim Meyers, Senior Advisor, BCG